Teachers Retirement System of The State of Kentucky Reduces Stock Position in Tenet Healthcare Corporation $THC

Teachers Retirement System of The State of Kentucky trimmed its holdings in Tenet Healthcare Corporation (NYSE:THC) by 9.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,233 shares of the company’s stock after selling 3,000 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Tenet Healthcare were worth $5,732,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the stock. Norges Bank purchased a new stake in Tenet Healthcare during the 2nd quarter worth about $206,981,000. Boston Partners lifted its holdings in shares of Tenet Healthcare by 95.0% in the second quarter. Boston Partners now owns 2,267,142 shares of the company’s stock worth $398,949,000 after buying an additional 1,104,500 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of Tenet Healthcare by 375.7% in the second quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock valued at $139,085,000 after acquiring an additional 624,125 shares during the period. Holocene Advisors LP purchased a new position in Tenet Healthcare during the second quarter valued at approximately $102,855,000. Finally, WCM Investment Management LLC increased its holdings in Tenet Healthcare by 244.4% during the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after acquiring an additional 362,083 shares during the period. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. JPMorgan Chase & Co. boosted their price target on shares of Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Guggenheim boosted their target price on Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a research report on Friday, February 13th. Royal Bank Of Canada raised their price target on Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a report on Thursday, February 12th. Wells Fargo & Company restated an “overweight” rating and issued a $265.00 price objective on shares of Tenet Healthcare in a research report on Monday, February 16th. Finally, Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Sunday. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and an average target price of $247.67.

Tenet Healthcare Stock Performance

NYSE:THC opened at $242.90 on Wednesday. The company has a market capitalization of $21.12 billion, a price-to-earnings ratio of 15.68, a PEG ratio of 1.16 and a beta of 1.39. The business has a 50 day moving average of $207.62 and a 200 day moving average of $201.09. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $243.72.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. During the same period last year, the firm posted $3.44 earnings per share. The business’s revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, sell-side analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In other news, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider R. Scott Ramsey sold 8,017 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 34,195 shares of company stock worth $7,912,606 over the last three months. Company insiders own 0.81% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.